Compare UP & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UP | WVE |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | N/A | 2015 |
| Metric | UP | WVE |
|---|---|---|
| Price | $0.67 | $16.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $27.53 |
| AVG Volume (30 Days) | 4.0M | ★ 12.9M |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $757,468,000.00 | $109,230,000.00 |
| Revenue This Year | $174.46 | N/A |
| Revenue Next Year | N/A | $31.09 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 103.75 |
| 52 Week Low | $0.59 | $5.28 |
| 52 Week High | $3.50 | $21.73 |
| Indicator | UP | WVE |
|---|---|---|
| Relative Strength Index (RSI) | 36.10 | 65.79 |
| Support Level | $0.64 | $15.86 |
| Resistance Level | $0.87 | $21.73 |
| Average True Range (ATR) | 0.10 | 1.55 |
| MACD | 0.03 | 0.94 |
| Stochastic Oscillator | 28.57 | 61.79 |
Wheels Up Experience Inc is a provider of on-demand private aviation in the United States. It is pioneering data and technology-driven solutions that connect consumers to safety-vetted and verified private aircraft. It connects private flyers to aircraft, and one another, through an open platform that enables life's most important experiences. Its offering is delivered through a mix of programmatic and charter options that strategically utilize its owned and leased aircraft fleet and an "asset-light" charter model to deliver a greater range of global travel alternatives. The company operates in a single operating and reportable segment, private aviation services. Geographically the company generates the majority of its revenue from the United States.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.